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ABSTRACT
Objective: Analyze nasal colonization by oxacillin-sensitive and oxacillin-resistant 
Staphylococcus aureus in people with HIV/AIDS (PWHA) at days 1 and7 of hospitalization. 
Method: A prospective observational study conducted in a hospital in the countryside 
of the state of São Paulo. Nasal swab samples were collected and analyzed through 
microbiological identification, at days 1 and 7 of hospitalization ofPWHA, between 
August 2011 and January 2014. Data were analyzed via IBM SPSS®, version 20.0. 
Results: Nasal secretion samples were collected from 187 (50.1%) PWHA at days 1 and 
7 of hospitalization. Of these, Staphylococcus aureus was identified in 64 (34.2%) PWHA. 
Conclusion: At day 1 of hospitalization, 27 PWHA were identified with Staphylococcus 
aureus; 27 PWHA presented colonization by Staphylococcus aureus at days 1 and 7, and 10 
PWHA only at day 7. Of 64 PWHA colonized by Staphylococcus aureus, the susceptibility 
profile of isolated Staphylococcus aureus was oxacillin-resistant in 25 PWHA.
DESCRIPTORS
HIV Infections; Hospitalization; Staphylococcus aureus; Oxacillin.
615
Pio DPM, Reinato LAF, Lopes LP, Gir E
www.ee.usp.br/reeusp Rev Esc Enferm USP · 2016;50(4):614-618
INTRODUCTION
Human beings are natural reservoirs of Staphylococcus 
aureus, a bacterium that is especially found in the nose, va-
gina, pharynx and/or injured skin surfaces(1). Once natural 
protection barrier is past, the microorganism can access 
underlying layers of the skin and, in favorable conditions, 
it may cause an infection(2-3).
An infection situation can be very serious in immu-
nocompromised patients, such as those with the human 
immunodeficiency virus (HIV), serious burns and cancer, 
increasing the morbimortality rate, length of hospital stay 
and healthcare costs(4).
Infections caused by Staphylococcus aureus have been 
considered the major cause of morbimortality of people 
living with HIV/AIDS (PWHA), due to virulence factor 
of this microorganism and its resistance to antibiotics. 
Methicillin-resistant Staphylococcus aureus (MRSA) was 
first described in Europe by Jevons in 1961 as a noso-
comial pathogen. Since then, microbial resistance is one 
of the major concerns of public health, with serious eco-
nomic, social and political implications that affect indi-
viduals globally, going beyond environmental and ethni-
cal boundaries(5).
People with HIV/AIDS present higher incidence of 
Staphylococcus aureus when compared to non-infected peo-
ple(4).Thus, HIV infection is a risk factor for colonization 
and infection by MRSA(6-8).
Despite the outstanding progress with the antiretrovi-
ral therapy for HIV patients, several undesirable situations 
still require hospitalization, exposing them to the nosoco-
mial microbiota. The main causes of PWHA hospitaliza-
tion include: gastrointestinal diseases, bacterial infections 
and cardiovascular diseases(9).The hospitalization process 
requires interventions that change the natural microbiota 
of the patient, due to an aggravated health condition, like 
systemic diseases or use of medication, invasive procedures 
or site contamination.
A study conducted in Ireland demonstrated that the 
effect of an early MRSA detection facilitates screen-
ing and early patient isolation, leading to reduced cross 
infection(10). Based on that, identifying colonization by 
multidrug-resistant microorganisms at hospital admis-
sion of PWHA allows the adoption of clinical measures, 
such as: isolation and decolonization techniques to pre-
vent microorganism dissemination and, consequently, a 
possible infection.
It is important to recognize the particularities involv-
ing PWHA when seeking care individualization to these 
patients. The nosocomial environment can have a direct 
influence on multidrug-resistant microorganism dissemi-
nation in this population. Thus, the objective of this study 
was to analyze nasal colonization by oxacillin-sensitive 
and oxacillin-resistant Staphylococcus aureus in PWHA at 
days 1 and 7 of hospitalization, correlating it to sociode-
mographic and clinical findings. This study assumes that 
a period of 7 days or more of hospitalization can change 
the nasal colonization of PWHA in relation to the pres-
ence or not of oxacillin-sensitive or oxacillin-resistant 
Staphylococcus aureus.
METHOD
This is a prospective observational study conducted in 
two specialized units that provide care to patients with in-
fectious diseases of a university hospital in the countryside 
of the state of São Paulo.
This study was approved by the Ethics Committee of 
the Escola de Enfermagem de Ribeirão Preto da USP, ob-
serving the recommendations in Resolution 196/96 of the 
Brazilian Health Council (Protocol nº 1304/2011).
This study used convenience sampling and included all 
participants who met the inclusion criteria: being 18 years 
old and over, being aware of the HIV/AIDS infection di-
agnosis and providing material collection at days 1 and 7 
of hospitalization .The exclusion criteria were: people liv-
ing with HIV/AIDS using any ventilation device and/or 
presenting a clinical condition preventing material collec-
tion. For participants with more than one hospitalization 
period, this study considered only the first one.
The participants were selected by collection assistants, 
who received a specific training from August 2011 to 
January 2014. At day 1 of hospitalization, the patient was 
invited to participate and received information regarding 
the ethical aspects of this study. After the patient approval, 
the participant signed an informed consent form.
Sociodemographic and clinical data were collected 
through individual interviews and from clinical records 
of the patient. Nasal secretion samples were obtained 
with a dry swab with sterile Stuart medium (COPAN®), 
rubbed on both nares, at day 1 of hospitalization to check 
whether the PWHA was already colonized by oxacillin-
sensitive or oxacillin-resistant Staphylococcus aureus, and at 
day 7 of hospitalization to check for oxacillin-sensitive 
or oxacillin-resistant Staphylococcus aureus, as compared to 
the condition identified at day 1. The swabs were kept at 
ambient temperature (30ºC) in plastic capped containers 
that were sent to the microbiological analysis laboratory 
within 24 hours of collection, where they were placed on 
agar blood and mannitol plates.
The isolation and phenotypic identification of 
Staphylococcus aureus were performed using an automated 
method, with the help of Vitek® (BioMérieuxTM) sys-
tem cards. Resistance to antimicrobials was tested using 
(BioMérieuxTM) AST-P585 card. When a nasal coloniza-
tion by Staphylococcus aureus was confirmed in study par-
ticipants, the Hospital Infection Control Commission was 
informed, which in turn, informed the patient’s physician, 
who analyzed with the commission the institution’s de-
colonization protocol prescription.
Data were organized on a spreadsheet produced with 
Microsoft Office Excel for Windows 7 using double entry 
and were validated subsequently. The final spreadsheet was 
transported and analyzed using IBM SPSS®, version 20.0 
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for Windows, performing operations of new variable cre-
ation, categorization and grouping, and then data analysis 
of descriptive and analytical statistics, using the chi-square 
test, p value of 0.05.
RESULTS
Of 373 participants analyzed in the study period, 187 
(50.1%) were eligible and met the inclusion criteria; in 
123 (65.7%), the cultures were negative at day 7 (Table 1).
Table 1 – Distribution of PWHA according to the nasal coloniza-
tion by oxacillin-sensitive or oxacillin-resistant Staphylococcus 
aureus at days 1 and 7 of hospitalization – Ribeirão Preto, SP, Bra-
zil, 2011-2014.
Day 1 Day 7
Positive culture 54 (28.8) 64 (34.2)
Oxacillin-sensitive Staphylococcus 
aureus 39 39
Oxacillin-resistant Staphylococcus 
aureus 15 25
Negative culture 133 (71.1) 123 (65.8)
Total 187 (100) 187 (100)
Note: (n=187).
Of 64 (34.2%) participants with positive culture to 
Staphylococcus aureus, 27 (42.2%) showed persistent mi-
croorganism at days 1 and 7 of hospitalization, and three 
(4.7%) presented a different profile of oxacillin sensi-
tivity, as at day 7, oxacillin-resistant Staphylococcus au-
reus was observed. Seven (10.9%) participants presented 
Staphylococcus aureus only at day 7 of hospitalization; 
however, the profile of susceptibility showed oxacillin-
resistant microorganism.
Regarding participant characterization, 59.4% were 
male. The predominant age was ≥ 40 and ≤ 59 years in 
49.7% of the sample. In terms of educational attainment, 
39.0% had not completed higher education. The clinical 
diagnosis of HIV infection 5 years or less was observed 
in 38.5% of the participants; 77.0% were submitted to an 
invasive procedure during hospitalization; 59.9% presented 
detectable viral load for HIV; 69.0% presented CD4+T 
lymphocyte counts of 350 cell/mm3 or less; 72.2% were tak-
ing an antimicrobial; 58.8% did not have the antiretroviral 
therapy prescribed during hospitalization (Table 2).
Table 2 – Distribution of PWHA at day 7 of hospitalization ac-
cording to the nasal colonization by Staphylococcus aureus and 
sociodemographic and clinical variables – Ribeirão Preto, SP, 
Brazil, 2011-2014.
Variables
Colonized Not colonized
n=64(%) n= 123(%)
Sex
Male 47(25.2) 64(34.2)
Female 17(9.0) 59(31.5)
Variables
Colonized Not colonized
n=64(%) n= 123(%)
Age (years)
≥ 19 and ≤ 39 34(18.1) 52(27.8)
≥40 and ≤ 59 25(13.3) 68(36.3)
≥ 60 5(2.6) 3(1.6)
School attainment
Illiterate and/or incomplete 
basic education 9(4.8) 24(12.8)
Incomplete high school 13(6.9) 17(9.1)
Incomplete higher 
education 26(13.9) 47(25.1)
Complete higher education 16(8.5) 35(18.7)
Time since diagnosis of HIV 
(year)
≤ 5 22(11.7) 50(26.7)
5 to 15 22(11.7) 41(21.9)
≥ 15 18(9.6) 31(16.5)
Did not know 2(1.0) 1(0.5)
Invasive procedure during 
hospitalization
Yes 51(27.2) 93(49.7)
No 13(6.9) 30(16.0)
Viral load (copies/ml)
Detectable 16(8.5) 25(13.3)
Undetectable 34(18.1) 78(41.7)
Not informed 14(7.4) 20(10.6)
CD4+ T lymphocyte 
counts (cell/mm3)
≤ 350 47(25.1) 82(43.8)
≥ 350 11(5.8) 26(13.9)
Not informed 6(3.2) 15(8.0)
Use of antibiotics
Yes 43(22.9) 92(49.1)
No 21(11.2) 31(16.5)
Antiretroviral prescribed in 
hospitalization
Yes 27(14.4) 50(26.7)
No 37(19.7) 73(39.0)
 Note: (n=187)
continued...
...continuation
The chi-square test was used, p value of 0.05, correlat-
ing the following variables: sex, sexual relation in the last6 
months, use of antibiotics during hospitalization, antiretro-
viral therapy prescribed during hospitalization and invasive 
procedure during hospitalization with nasal colonization by 
Staphylococcus aureus (Table 3).
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RESUMO
Objetivo: Analisar a colonização nasal por Staphylococcus aureus sensíveis e resistentes à oxacilina de pessoas vivendo com HIV/aids 
(PVHA) no primeiro e no sétimo dia de internação hospitalar. Método: Estudo prospectivo observacional realizado em um hospital 
do interior paulista. Foram coletadas e analisadas, por meio de identificação microbiológica, amostras de swab nasal no primeiro e no 
sétimo dia de internação hospitalar de PVHA, no período de agosto/2011 e janeiro/2014. A análise dos dados foi realizada por meio 
do IBM SPSS®, versão 20.0. Resultados: Em 187 (50,1%) PVHA foram coletadas amostras de secreção nasal no primeiro e sétimo 
Table 3 – Association of PWHA at day 7 of hospitalization according to the nasal colonization by Staphylococcus aureus and behavioral 
and clinical variables – Ribeirão Preto, SP, Brazil, 2011-2014.
Colonized
Yes No
Sex
Male 47 64
p = 0.005
Female 17 59
Sexual relation in the last 6 months
Yes 31 49
p = 0.259
No 33 74
Use of antibiotics during hospitalization
Yes 43 92
p = 0.271
No 21 31
Antiretroviral therapy prescribed 
during hospitalization
Yes 27 50
p = 0.839
No 37 73
Invasive procedure during hospitalization
Yes 51 93
p = 0.530
No 13 30
Note: (n=187)
DISCUSSION
This study analyzed the nasal mucosa as the site of colo-
nization by Staphylococcus aureus. A case-control study con-
ducted in Singapore, which attempted to identify MRSA 
in people with HIV/AIDS at hospital admission, showed 
the main site of colonization by this microorganism were 
the nares of participants(7).
In this study, male PWHA presented higher rates of nasal 
colonization by Staphylococcus aureus, in agreement with the 
findings from a study conducted in Barcelona to investigate 
the prevalence of MRSA in patients with HIV/AIDS(11).
Monitoring the dissemination of Staphylococcus aureus in 
this population with HIV/AIDS contributes to infection 
control and prevention programs and the survival of these 
patients(5); for this reason, surveillance policies are viable for 
patients at risk for colonization and infection by multidrug-
resistant microorganisms. It is essential to identify this con-
dition of the patient at hospital admission and monitor the 
patient during hospitalization.
The risk factors indicated as predisposing factors for the 
susceptibility of people with HIV/AIDS to MRSA are: 
CD4+T lymphocyte count below 500 cell/mm3, HIV viral 
load of 400 copies/ml or above, use of injectable drugs, old 
age, prior hospitalization and invasive procedures(7,12). Based 
on that, most participants of this study presented most risk 
factors indicated as predisposing factors for colonization by 
MRSA in this investigated population.
At day 7 of hospitalization, Staphylococcus aureus was ob-
served in 10 (15.6%) participants; of these, seven (70.0%) 
were oxacillin resistant, similar to a study conducted with 
long-term hospitalized patients who presented higher 
prevalence of MRSA when compared to other multidrug-
resistant microorganisms(13).
Another relevant factor is that most participants did not 
have antiretroviral medications prescribed during hospital-
ization, but the literature shows one of the main causes of 
hospitalization of PWHA is their non-adherence to pre-
scribed antiretroviral treatment, causing a greater exposure 
of these individuals to the nosocomial environment(14-15).
The limitations of this study refer to the lower number 
of participant follow-up at day 7 of hospitalization versus 
day 1, due to discharges, refusals or deaths. In addition, a 
study on prevalence and risk factors for MRSA in people 
with HIV/AIDS indicates the importance of investigating 
several sites of possible colonization by Staphylococcus aureus 
in this population, not only the nares(13,16).
CONCLUSION
Of 187 (100%) participants who provided nasal secre-
tion samples at days 1 and 7 of hospitalization, 64 (34.2%) 
presented nasal colonization by Staphylococcus aureus: 27 
(14.4%) at day 1, 10 (5.3%) at day 7, and 27 (14.4%) at 
both days 1 and 7, characterizing persistent colonization 
by Staphylococcus aureus.
Resistance to oxacillin was observed in 25 (13.3%) par-
ticipants; 10 (5.3%) of these only at day 7 of hospitalization.
It is noteworthy that most participants colonized by 
Staphylococcus aureus were male, reported no sexual relations 
in the last 6 months, were using antibiotics, had no antiret-
roviral therapy prescribed and were submitted to an invasive 
procedure during hospitalization.
618 Rev Esc Enferm USP · 2016;50(4):614-618 www.ee.usp.br/reeusp
Staphylococcus aureus and the oxacillin sensitivity profile in hospitalized people with HIV/AIDS
dia de internação. Destas, em 64 (34,2%) foi identificado Staphylococcus aureus. Conclusão: No primeiro dia de internação observou-
se 27 PVHA colonizadas por Staphylococcus aureus; em 27 PVHA houve a persistência da colonização por Staphylococcus aureus no 
primeiro e no sétimo dia; em 10 PVHA, somente no sétimo dia. Das 64 PVHA colonizadas por Staphylococcus aureus, em 25 o perfil de 
suscetibilidade do Staphylococcus aureus isolado foi resistente à oxacilina.
DESCRITORES
Infecções por HIV; Hospitalização; Staphylococcus aureus; Oxacilina.
RESUMEN
Objetivo: Analizar  la colonización nasal por Staphylococcus aureus sensibles y resistentes a la oxacilina de personas viviendo con VIH/
Sida (PVVS) el primer y séptimo día de estancia hospitalizar. Método: Estudio prospectivo observacional, realizado en un hospital 
del interior del Estado de São Paulo. Fueron recogidas y analizadas, mediante identificación microbiológica, muestras de swab nasal el 
primer y el séptimo día de estancia hospitalaria de PVVS, en el período de agosto/2011 a enero/2014. Se realizó el análisis de los datos 
mediante el IBM SPSS®, versión 20.0. Resultados: En 187 (50,1%) PVVS, fueron recogidas muestras de secreción nasal el primer y 
séptimo día de estancia hospitalaria. De esas, en 64 (34,2%) fue identificado Staphylococcus aureus. Conclusión: El primer día de estancia 
se observó 27 PVVS colonizadas por Staphylococcus aureus; en 27 PVVS hubo la persistencia de la colonización por Staphylococcus aureus 
el primer y el séptimo día; en 10 PVVS, solo el séptimo día. De las 64 PVVS colonizadas por Staphylococcus aureus, en 25 el perfil de 
susceptibilidad del Staphylococcus aureus aislado fue resistente a la oxacilina.
DESCRIPTORES
Infecciones por VIH; Hospitalización; Staphylococcus aureus; Oxacilina.
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